Podcast: Therapy for RR MM: Expert Answers
Optimizing Therapy for Relapsed/Refractory Multiple Myeloma: Expert Answers to Your Questions

Released: June 17, 2021

Expiration: June 16, 2022

Activity

Progress
1
Course Completed

In this podcast episode, Suzanne Lentzsch, MD, PhD, and  Saad Z. Usmani, MD, MBA, FACP, discuss how they select optimal treatment for relapsed/refractory (R/R) multiple myeloma (MM) and answer audience questions from a live webinar. Topics include:

  • Selecting optimal triplet regimen after first relapse
  • Sequencing treatment options after multiple relapses
  • Managing patient expectations when selecting treatments
  • Emerging treatment options for R/R MM

Presenters:  

Suzanne Lentzsch, MD, PhD
Director, Multiple Myeloma and Amyloidosis Program
Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

Saad Z. Usmani, MD, MBA, FACP
Clinical Professor of Medicine
Department of Hematologic Oncology & Blood Disorders
Division Chief
Plasma Cell Disorders Division
Levine Cancer Institute/Atrium Health
Charlotte, North Carolina